当前位置: X-MOL 学术J. Alzheimer’s Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Impact of Serum Calcium Levels on Alzheimer's Disease: A Mendelian Randomization Study.
Journal of Alzheimer’s Disease ( IF 4 ) Pub Date : 2020-05-04 , DOI: 10.3233/jad-191249
Yating He 1 , Haihua Zhang 2 , Tao Wang 3, 4 , Zhifa Han 5, 6, 7 , Qing-Bin Ni 8 , Kun Wang 8 , Longcai Wang 9 , Yan Zhang 10 , Yang Hu 11 , Shuilin Jin 12 , Bao-Liang Sun 13 , Guiyou Liu 2, 14, 15
Affiliation  

Background:Altered calcium homeostasis is hypothesized to underlie Alzheimer’s disease (AD). However, it remains unclear whether serum calcium levels are genetically associated with AD risk. Objective:To develop effective therapies, we should establish the causal link between serum calcium levels and AD. Methods:Here, we performed a Mendelian randomization study to investigate the causal association of increased serum calcium levels with AD risk using the genetic variants from a large-scale serum calcium genome-wide association study (GWAS) dataset (61,079 individuals of European descent) and a large-scale AD GWAS dataset (54,162 individuals including 17,008 AD cases and 37,154 controls of European descent). Here, we selected the inverse-variance weighted (IVW) as the main analysis method. Meanwhile, we selected other three sensitivity analysis methods to examine the robustness of the IVW estimate. Results:IVW analysis showed that the increased serum calcium level (per 1 standard deviation (SD) increase 0.5 mg/dL) was significantly associated with a reduced AD risk (OR = 0.57, 95% CI 0.35–0.95, p = 0.031). Meanwhile, all the estimates from other sensitivity analysis methods were consistent with the IVW estimate in terms of direction and magnitude. Conclusion:In summary, we provided evidence that increased serum calcium levels could reduce the risk of AD. Meanwhile, randomized controlled study should be conducted to clarify whether diet calcium intake or calcium supplement, or both could reduce the risk of AD.

中文翻译:

血清钙水平对阿尔茨海默病的影响:一项孟德尔随机研究。

背景:假设改变的钙稳态是阿尔茨海默病 (AD) 的基础。然而,尚不清楚血清钙水平是否与 AD 风险存在遗传相关性。目的:为了开发有效的治疗方法,我们应该确定血清钙水平与 AD 之间的因果关系。方法:在这里,我们进行了一项孟德尔随机化研究,以使用来自大规模血清钙全基因组关联研究 (GWAS) 数据集(61,079 名欧洲人后裔)的遗传变异来研究血清钙水平升高与 AD 风险之间的因果关系和一个大规模的 AD GWAS 数据集(54,162 个人,包括 17,008 个 AD 病例和 37,154 个欧洲血统对照)。在这里,我们选择了逆方差加权(IVW)作为主要的分析方法。同时,我们选择了其他三种敏感性分析方法来检验 IVW 估计的稳健性。结果:IVW 分析表明,血清钙水平升高(每 1 个标准差 (SD) 增加 0.5 mg/dL)与 AD 风险降低显着相关(OR = 0.57,95% CI 0.35–0.95,p = 0.031)。同时,其他敏感性分析方法的估计值在方向和幅度上都与IVW估计值一致。结论:总之,我们提供了血清钙水平升高可以降低 AD 风险的证据。同时,应进行随机对照研究来阐明饮食钙摄入或钙补充,或两者都可以降低AD的风险。IVW 分析表明,血清钙水平升高(每 1 个标准差 (SD) 增加 0.5 mg/dL)与 AD 风险降低显着相关(OR = 0.57,95% CI 0.35–0.95,p = 0.031)。同时,其他敏感性分析方法的估计值在方向和幅度上都与IVW估计值一致。结论:总之,我们提供了血清钙水平升高可以降低 AD 风险的证据。同时,应进行随机对照研究来阐明饮食钙摄入或钙补充,或两者都可以降低AD的风险。IVW 分析表明,血清钙水平升高(每 1 个标准差 (SD) 增加 0.5 mg/dL)与 AD 风险降低显着相关(OR = 0.57,95% CI 0.35–0.95,p = 0.031)。同时,其他敏感性分析方法的估计值在方向和幅度上都与IVW估计值一致。结论:总之,我们提供了血清钙水平升高可以降低 AD 风险的证据。同时,应进行随机对照研究来阐明饮食钙摄入或钙补充,或两者都可以降低AD的风险。其他敏感性分析方法的所有估计值在方向和幅度方面都与 IVW 估计值一致。结论:总之,我们提供了血清钙水平升高可以降低 AD 风险的证据。同时,应进行随机对照研究来阐明饮食钙摄入或钙补充,或两者都可以降低AD的风险。其他敏感性分析方法的所有估计值在方向和幅度方面都与 IVW 估计值一致。结论:总之,我们提供了血清钙水平升高可以降低 AD 风险的证据。同时,应进行随机对照研究来阐明饮食钙摄入或钙补充,或两者都可以降低AD的风险。
更新日期:2020-06-19
down
wechat
bug